Standardized Amla Shows Promise for Lipid Management

A standardized amla extract is gaining attention as a science-backed botanical for cardiovascular wellness. In a 12-week randomized, double-blind, placebo-controlled trial involving 98 participants, Tri-Low® at 500 mg twice daily was associated with reductions of up to 20% in LDL-C, 34% in triglycerides and 24% in total cholesterol. The extract, derived from Phyllanthus emblica, is standardized for triterpenoids, polyphenols and ALA-related fractions, offering a consistent bioactive profile for nutraceutical formulations targeting healthy lipid balance and broader metabolic health.

Source : https://www.nutraingredients.com/News/Promotional-features/standardized-amla-extract-can-support-cardiovascular-health/